newsfilter
← Latest News
GlobeNewswire·

BioCardia Reports Second Quarter 2025 Business Highlights and Financial Results

SUNNYVALE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported